At the conclusion of a primary percutaneous coronary intervention for ST-segment elevation
myocardial infarction, and after the cardiologist makes certain that there is no residual …

Primary percutaneous angioplasty (pPCI), represents the reperfusion strategy of choice for
patients with STEMI according to current international guidelines of the European Society of …

This review is a historical account about purinergic signalling in the heart, for readers to see
how ideas and understanding have changed as new experimental results were published …

Coronary no-reflow phenomenon is a lethal mechanism of ongoing myocardial injury,
following successful revascularization of an infarct-related coronary artery. Incidence of this …

Background: The coronary no-reflow phenomenon is an adverse complication of
percutaneous coronary interventions (PCI) which significantly worsens the outcome and …

Efficacy of Adenosine in Patients With Acute Myocardial Infa... : Medicine Efficacy of Adenosine
in Patients With Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary …

Objectives We sought to evaluate the impact of direct stenting technique on angiographic
and clinical outcomes of patients with ST‐segment elevation myocardial infarction (STEMI) …

In recent decades coronary microvascular dysfunction has been increasingly identified as a
relevant contributor to several cardiovascular conditions. Indeed, coronary microvascular …

Background: This study aimed to analyze the associations between no-reflow (NR)
phenomenon development and whole-blood viscosity in patients with ST-elevated …

Background—The MGuard, a bare metal stent covered with a polymer mesh, was designed
to reduce distal embolization during percutaneous coronary intervention in ST-segment …